LEADER 02976oam 2200649I 450 001 9910462160603321 005 20200520144314.0 010 $a1-283-84509-1 010 $a1-136-02462-X 010 $a0-203-60906-9 024 7 $a10.4324/9780203609064 035 $a(CKB)2670000000277198 035 $a(EBL)1075415 035 $a(OCoLC)821176495 035 $a(SSID)ssj0000783986 035 $a(PQKBManifestationID)11431657 035 $a(PQKBTitleCode)TC0000783986 035 $a(PQKBWorkID)10760903 035 $a(PQKB)11093633 035 $a(MiAaPQ)EBC1075415 035 $a(Au-PeEL)EBL1075415 035 $a(CaPaEBR)ebr10628912 035 $a(CaONFJC)MIL415759 035 $a(OCoLC)819379775 035 $a(EXLCZ)992670000000277198 100 $a20180706d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aPlanning the night-time city /$fMarion Roberts and Adam Eldridge 210 1$aLondon ;$aNew York :$cRoutledge,$d2009. 215 $a1 online resource (257 p.) 300 $aDescription based upon print version of record. 311 $a0-415-43618-4 311 $a0-415-43617-6 320 $aIncludes bibliographical references and index. 327 $aCover; Planning the Night-time City; Copyright; Contents; Figures; Tables; Acknowledgements; Chapter 1 Introduction; Chapter 2 Cities at night; Chapter 3 Visions of the night-time city; Chapter 4 Party cities; Chapter 5 Binge-drinking Britain?; Chapter 6 Regulating consumption: Mainland Britain; Chapter 7 Regulating licensing: The dream of a continental style of drinking; Chapter 8 Planning and managing the night-time city: Rhetoric and pragmatism; Chapter 9 Consumers; Chapter 10 Night-time cities, night-time futures; Bibliography; Index 330 $aThe night-time economy represents a particular challenge for planners and town centre managers. In the context of liberalised licensing and a growing culture around the '24-hour city', the desire to foster economic growth and to achieve urban regeneration has been set on a collision course with the need to maintain social order.Roberts and Eldridge draw on extensive case study research, undertaken in the UK and internationally, to explain how changing approaches to evening and night-time activities have been conceptualised in planning practice. The first to synthesise recent debates 606 $aCity planning$zGreat Britain 606 $aLifestyles$zGreat Britain 606 $aNightlife$zGreat Britain 608 $aElectronic books. 615 0$aCity planning 615 0$aLifestyles 615 0$aNightlife 676 $a307.1/2160941 700 $aRoberts$b Marion.$0770156 701 $aEldridge$b Adam$0770157 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910462160603321 996 $aPlanning the Night-time City$91570849 997 $aUNINA LEADER 04610nam 2200673Ia 450 001 9910145291403321 005 20230828214450.0 010 $a1-281-32201-6 010 $a9786611322014 010 $a0-470-75061-8 010 $a0-470-75022-7 035 $a(CKB)1000000000403880 035 $a(EBL)351017 035 $a(OCoLC)437214022 035 $a(SSID)ssj0000123721 035 $a(PQKBManifestationID)11159782 035 $a(PQKBTitleCode)TC0000123721 035 $a(PQKBWorkID)10011112 035 $a(PQKB)10632791 035 $a(MiAaPQ)EBC351017 035 $a(Au-PeEL)EBL351017 035 $a(CaPaEBR)ebr10232989 035 $a(CaONFJC)MIL132201 035 $a(EXLCZ)991000000000403880 100 $a20051129d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical trials explained$b[electronic resource] $ea guide to clinical trials in the NHS for healthcare professionals /$feditors, Derek Stewart ... et al. ; produced by the British Medical Journal (BMJ), in association with the National Translational Cancer Research Network (NTRAC) and Emergency Care Research Institute (ECRI) 210 $aMalden, MA $cBlackwell Pub.$dc2006 215 $a1 online resource (114 p.) 300 $aDescription based upon print version of record. 311 $a0-7279-1858-3 320 $aIncludes bibliographical references and index. 327 $aClinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals; Contents; Preface; Acknowledgements; Chapter 1 Overview and Purpose of this Guide to Clinical Trials in the NHS; Overview and purpose of this guide; Who should use this guide to clinical trials in the NHS?; Chapter 2 Clinical Trials Explained; What are clinical trials?; Why are clinical trials needed?; Who is involved in a clinical trial?; How are clinical trials designed and approved?; Progression of a medical intervention through the clinical trial phases; Summary 327 $aChapter 3 Clinical Trial Approval, Regulation and FundingHow are clinical trials approved and regulated?; Ethical approval; Informed consent; How are trials managed?; Who pays for a clinical trial?; Summary; Chapter 4 Understanding Clinical Trial Design and Results; Understanding randomisation and blinding in clinical trials; Understanding controls and placebos; Why are placebos used in clinical trials?; What about trials that are not controlled or blinded?; Understanding clinical trial results; Summary; Chapter 5 Questions About Clinical Trials: A Framework for Discussion 327 $aWhat are patients' rights?Why do patients take part in clinical trials?; Why do patients decline to take part in a clinical trial or withdraw from a clinical trial they are involved in?; How can patients be empowered during their involvement in a clinical trial?; Will patients involved in clinical trials need extra help and support from their carers?; What are the likely costs of and reimbursement for patients participating in clinical trials?; Summary; Appendix A Finding Out About Clinical Trials that are Currently or Soon to be Recruiting 327 $aAppendix B ECRI Evidence Report: Patients' Reasons for Participation in Clinical Trials and Effect of Trial Participation on Patient OutcomesGlossary; Index 330 $aWhat will happen during and after a clinical trial?How will a trial affect my quality of life?What are the benefits and risks of a trial?What does giving consent mean and what will it involve?Will I incur costs during and because of the trial? These are the questions that should be raised every time a health care professional talks through with a patient the pros and cons of entering a clinical trial. Clinical Trials Explained has been designed in consultation with doctors and patients who have taken part in trials, providing an essential and detailed gu 606 $aClinical trials$zGreat Britain 606 $aClinical trials$xDecision making 606 $aNational health services$zGreat Britain 615 0$aClinical trials 615 0$aClinical trials$xDecision making. 615 0$aNational health services 676 $a610.72/4 676 $a615.50724 701 $aStewart$b Derek$f1951-$0939840 712 02$aNational Translational Cancer Research Network. 712 02$aEmergency Care Research Institute. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910145291403321 996 $aClinical trials explained$92119014 997 $aUNINA LEADER 01255nam0 22002891i 450 001 UON00504323 005 20231205105428.933 010 $a978-06-7405-082-2 100 $a20210108d2016 |0itac50 ba 101 $aeng 102 $aUS 105 $a|||| ||||| 200 1 $aBeyond Timbuktu$eAn Intellectual History of Muslim West Africa$fOusmane Oumar Kane 210 $aCambridge, Mass.$cHarvard University Press$d2016 215 $a282 p.$d25 cm 606 $aIslam$x Diffusione$xAfrica occidentale$xStoria$3UONC098043$2FI 620 $aUS$dCambridge (Mass.)$3UONL000262 676 $a297.096$cIslam - Africa$v21 700 1$aKANE$bOusmane Oumar$3UONV093397$0793247 712 $aHarvard University Press$3UONV245793$4650 801 $aIT$bSOL$c20250613$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00504323 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI ST 491 $eSI 36922 5 491 951 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$bSI2021174 1J 20210108 996 $aBeyond Timbuktu$91774248 997 $aUNIOR